Covalon Technologies Ltd
XTSX:COV

Watchlist Manager
Covalon Technologies Ltd Logo
Covalon Technologies Ltd
XTSX:COV
Watchlist
Price: 3.8 CAD 7.04%
Market Cap: 104.1m CAD
Have any thoughts about
Covalon Technologies Ltd?
Write Note

Covalon Technologies Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Covalon Technologies Ltd
Capital Expenditures Peer Comparison

Comparables:
B
DRUG
TH
RPTX
AUPH
EDT

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Covalon Technologies Ltd
XTSX:COV
Capital Expenditures
-CA$605.2k
CAGR 3-Years
-179%
CAGR 5-Years
13%
CAGR 10-Years
-19%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Capital Expenditures
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Capital Expenditures
-$3m
CAGR 3-Years
-176%
CAGR 5-Years
1%
CAGR 10-Years
-15%
Repare Therapeutics Inc
NASDAQ:RPTX
Capital Expenditures
-$1.9m
CAGR 3-Years
5%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Capital Expenditures
-$283k
CAGR 3-Years
57%
CAGR 5-Years
-23%
CAGR 10-Years
-12%
Spectral Medical Inc
TSX:EDT
Capital Expenditures
-CA$213k
CAGR 3-Years
25%
CAGR 5-Years
-16%
CAGR 10-Years
-7%

See Also

What is Covalon Technologies Ltd's Capital Expenditures?
Capital Expenditures
-605.2k CAD

Based on the financial report for Jun 30, 2024, Covalon Technologies Ltd's Capital Expenditures amounts to -605.2k CAD.

What is Covalon Technologies Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-19%

Over the last year, the Capital Expenditures growth was 59%. The average annual Capital Expenditures growth rates for Covalon Technologies Ltd have been -179% over the past three years , 13% over the past five years , and -19% over the past ten years .

Back to Top